1. FRI0224 Rituximab selectively reduces igg4 levels in rheumatoid arthritis patients. (15th June 2017) Authors: Sarantopoulos, A; Gkougkourelas, I; Mytilinaiou, M; Klonizakis, P; Georgiadou, A; Boura, P Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P343 Maintenance of deep remission in Crohn's disease after switching from anti–TNF to ustekinumab. (27th May 2021) Authors: Mantzaris, G; Vraka, M; Beka, H; Georgiadi, T; Albani, F; Veretanos, C; Mountaki, K; Trikola, A; Archavlis, E; Christidou, A; Manolakis, A; Viazis, N; Karampekos, G; Philippidis, G; Hatzievangelinou, C; Tsatsa, A; Georgiadou, A; Panagopoulou, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗